Sat.Feb 18, 2023 - Fri.Feb 24, 2023

article thumbnail

The Important Role that Biopharmaceutics Plays in Accelerating Early-Phase Drug Development

Pharmaceutical Technology

Biopharmaceutics is a scientific discipline that examines the interrelationship of the physicochemical properties of the drug, the dosage form in which the drug is given, and the route of administration on the rate and extent of systemic drug absorption ( Applied Biopharmaceutics and Pharmacokinetics, Shargel, Wu-Pong and Yu, 5th Edition ).

article thumbnail

Biotech veteran Jodie Morrison on building drug ‘platforms’ and a support group for CEOs

Bio Pharma Dive

There comes a time when companies with platforms need to focus on their most advanced prospects, Morrison said, rather than sink all of their funds into building the technology

Drugs 309
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

He Slimed Me: FTC Hits GoodRx Over Unauthorized Use of Consumer Data

FDA Law Blog

By Jeffrey N. Wasserstein — GoodRx is a digital health platform familiar to many, and a prime example of a single player that operates in several different realms of the evolving and growing digital health marketplace.

Radiology 105
article thumbnail

Moderna pays US government $400M 'catch-up payment' under new COVID-19 vaccine license

Fierce Pharma

Moderna pays US government $400M 'catch-up payment' under new COVID-19 vaccine license esagonowsky Fri, 02/24/2023 - 09:18

Licensing 145
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

This webinar will go over the FDA's guidance on pharmacological and toxicological considerations for optimizing doses for prescription drugs.

article thumbnail

The one-shot cervical cancer vaccine paradigm

Pharmaceutical Technology

On December 20, 2022, the World Health Organization (WHO) updated its recommendations for cervical cancer vaccines in a bid to boost vaccination coverage.

article thumbnail

Medicaid, with planned payment pilot, girds for influx of pricey gene therapies

Bio Pharma Dive

The proposed model could help state Medicaid agencies explore different kinds of outcomes-based payment schemes, but may come too late to prepare for the first sickle cell gene therapy

More Trending

article thumbnail

Celebrating Black History Month 

Intouch Solutions

EVERSANA INTOUCH is once again celebrating Black History Month this February!

Nurses 98
article thumbnail

Biohacking is a response to societal problems, but is not the answer

Pharmaceutical Technology

Biohacking is a do-it-yourself biology movement that aims to improve the hacker’s health, appearance, performance, and overall well-being.

article thumbnail

Big pharma’s looming threat: a patent cliff of ‘tectonic magnitude’

Bio Pharma Dive

Many current top-selling products will lose patent protection by the end of the decade, putting pressure on companies to replace lost revenue with new medicines

article thumbnail

Pharma Marketers Need AI Now: How to deliver a truly personalized, omnichannel experience for your patients, with William Grambley, CEO of Allazo Health

Pharma Marketing Network

Marketing in the era of consumer-driven healthcare requires new tools and techniques. If you want patients to initiate therapy, you need to connect across more channels, more personally, and in the ways consumers prefer to be engaged.

article thumbnail

2022 Research: The Rapid Rise of Ocean Freight Visibility

Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.

article thumbnail

CSL’s first gene therapy for haemophilia B approved

Pharma Times

Boost for effected patients as HEMGENIX receives green light from European Commission

article thumbnail

GenScript ProBio and RVAC partner for Covid-19 vaccine pDNA

Pharmaceutical Technology

GenScript ProBio has announced a strategic collaboration with RVAC Medicines to manufacture GMP-grade plasmid DNA (pDNA) for the latter’s RVM-V001, an mRNA Covid-19 vaccine candidate. Under the agreement, GenScript ProBio will offer GMP plasmid manufacturing service for the RVM-V001 programme.

article thumbnail

FDA approves Sanofi’s long-lasting hemophilia drug

Bio Pharma Dive

Sanofi and its development partner, Sobi, claim the drug’s once-a-week dosing, and its effect on blood-clotting protein levels, will help it compete in the crowded market for hemophilia A treatments

article thumbnail

Hemab raises $135m in Series B cash to treat genetic bleeding disorders

BioPharma Reporter

The Danish-US biotech Hemab Therapeutics bags $135m to finance the clinical development of prophylactic treatments for genetic bleeding disorders including Glanzmann thrombasthenia and von Willebrand disease. Bio Developments

article thumbnail

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.

article thumbnail

Sangamo’s ST-920 demonstrates evidence of clinical benefit

Pharma Times

Phase 1/2 research shows that treatment could be very effective against Fabry disease

Research 131
article thumbnail

Patent wars: what’s behind Amgen’s possible win over Sanofi at the US Supreme Court

Pharmaceutical Technology

Amgen could be the winner of a high-stakes patent spat with Sanofi as tensions run high weeks before the March 27 US Supreme Court hearing. While some courts were previously on Sanofi’s side, it is possible that Amgen’s case could win this time, some legal experts say.

Antibody 262
article thumbnail

Medicare maintains limits on Eisai’s new Alzheimer’s drug

Bio Pharma Dive

Eisai and Biogen have data showing Leqembi slows cognitive decline, but CMS won’t budge until FDA converts its approval from accelerated to full

Drugs 275
article thumbnail

Eight essential steps for patient engagement, recruitment and retention

Outsourcing Pharma

Patient engagement, recruitment and retention are critical to achieving a successful clinical trial. Patient centricity

article thumbnail

Mandatory COVID Vaccination Policy Template

The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.

article thumbnail

Michael J. Fox Foundation funding boost for Newel Health’s Soturi

Pharma Times

Next phase of Newel Health’s digital therapeutics solution for Parkinson’s disease gains vital grant

129
129
article thumbnail

FDA grants Fast Track status for Biohaven’s taldefgrobep alfa to treat SMA

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has granted Fast Track designation for Biohaven ’s new anti-myostatin adnectin, taldefgrobep alfa, to treat spinal muscular atrophy (SMA).

Protein 246
article thumbnail

Sickle cell pipeline narrows as gene therapy developers rethink research plans

Bio Pharma Dive

Graphite Bio and Sangamo are stopping work on their respective sickle cell gene therapies, while Intellia revealed partner Novartis ended development of its genetic treatment for the blood disease

article thumbnail

Merck's COVID pill Lagevrio takes another hit with thumbs-down from EU regulator

Fierce Pharma

Merck's COVID pill Lagevrio takes another hit with thumbs-down from EU regulator kdunleavy Fri, 02/24/2023 - 09:38

article thumbnail

PBD Biotech broadens patent for tuberculosis diagnostic

Pharma Times

Africa-based trials for blood test which detects risk of disease progression are due to begin

Trials 121
article thumbnail

Pfizer’s Covid-19 vaccine sales forecasts upgraded with sales of $37bn in 2022

Pharmaceutical Technology

Pfizer and BioNTech’s Covid-19 vaccine, Comirnaty, had a phenomenal year with forecast sales of $37bn in 2022.

Sales 246
article thumbnail

Moderna inks another gene editing deal

Bio Pharma Dive

The messenger RNA specialist said Wednesday it is teaming up with Life Edit Therapeutics to develop therapies that can modify genes “in vivo &rdquo

article thumbnail

Sanofi, poised to rival Roche in hemophilia, nabs FDA approval for Altuviiio

Fierce Pharma

Sanofi, poised to rival Roche in hemophilia, nabs FDA approval for Altuviiio zbecker Thu, 02/23/2023 - 15:45

article thumbnail

UK atrial fibrillation research incorporates Brainomix

Pharma Times

Research will analyse how Huawei’s wearable technology detects atrial fibrillation in post-stroke patients

Research 121
article thumbnail

US FDA approves Apellis’ geographic atrophy therapy Syfovre

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has granted approval for Apellis Pharmaceuticals’ Syfovre (pegcetacoplan injection) to treat geographic atrophy (GA), an advanced form of age-related macular degeneration (AMD).

article thumbnail

Roche hands rights to lung cancer drug back to Blueprint

Bio Pharma Dive

Weeks after the Swiss drugmaker wrote off Gavreto’s accounting value, the biotech will regain responsibility for its commercialization

Drugs 246
article thumbnail

Reata, Friedreich’s Ataxia Patients Await Potential First Approval

BioSpace

Reata, Friedreich’s Ataxia Patients Await Potential First Approval 2/24/2023

98
article thumbnail

Janssen reveals vital niraparib data

Pharma Times

Research concerns the effect of niraparib when combined with abiraterone acetate plus prednisone

Research 120
article thumbnail

Frontotemporal dementia: the state of treatment development

Pharmaceutical Technology

Many have turned their attention to frontotemporal dementia (FTD) as the family of famed action star Bruce Willis announced his diagnosis last week.

article thumbnail

Reasons matter: uncovering insights into medication discontinuation in immunology

Bio Pharma Dive

Real-world data and advanced analytics reveal patterns and insights into why patients stop therapies

246
246